https://www.selleckchem.com/products/tak-779.html
To evaluate the efficacy and the feasibility of radiofrequency ablation to treat aldosterone-producing adenomas. In an open prospective bicentric pilot study, patients with hypertension on ambulatory blood pressure measurement, a primary aldosteronism, an adenoma measuring less than 4 cm, and confirmation of lateralization by adrenal venous sampling were recruited. The primary endpoint, based on ABPM performed at 6 months after the radiofrequency ablation, was a daytime SBP/DBP less than 135/85 mmHg without any antihypertensive drugs or
Like
Comment
Share
